评估SARS-CoV-2尖端突变D614G对传染性和致病性的影响
Erik Volz1, Verity Hill2, John T McCrone2
1MRC Centre for Global Infectious Disease Analysis, School of Public Health, Imperial College London, London, UK.
Cell
|December 4, 2020
概括
在英国,SARS-CoV-2 D614G尖端蛋白变体具有选择性优势. 虽然没有增加COVID-19死亡率,但614G变种与更高的病毒载量和年轻患者有关.
科学领域:
- 病毒学
- 人口遗传学
- 流行病学
背景情况:
- 在全球范围内,SARS-CoV-2 D614G尖端蛋白变体已经扩散,引发了关于其进化优势的问题.
- 它的增加频率可能归因于积极选择或随机创始人效应.
研究的目的:
- 调查英国SARS-CoV-2尖端蛋白D614G变体的阳性选择假设.
- 使用大量病毒基因组分析D614G变异的种群遗传学.
主要方法:
- 利用来自英国的超过25,000个SARS-CoV-2全基因组序列.
- 用于评估D614G变种相对于D614D变种的频率变化的基因分析.
- 检查了与D614G变种相关的临床数据,包括死亡率,严重程度,病毒载量和患者年龄.
主要成果:
- 人口遗传分析表明,614G变异的频率增加与选择性优势一致.
- 所有分析方法都没有发现积极选择的结论信号,尽管数据集很大,表现很好.
- 614G变种与较年轻患者的病毒载量和感染率较高有关,但没有增加COVID-19死亡率或临床严重程度.
- 在614G基因组的生长和大小上观察到显著的差异.
结论:
- 在英国,SARS-CoV-2 D614G 变种表现出与选择性优势一致的特征.
- 需要进行进一步的研究,以了解这种变异的遗传群动态观察到的差异的影响.
相关概念视频
Viral Mutations
38.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
38.1K
Single Nucleotide Polymorphisms-SNPs
17.5K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
17.5K
Infection
10.5K
When a pathogen enters the body and reproduces, it can cause an infection, damage body cells, and cause illness symptoms that eventually lead to disease. Therefore, its prevention requires breaking the chain of infection.
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
10.5K


